Long-term follow-up of a randomized trial comparing T-cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients.
Remberger
M
M
Division of Clinical Immunology, Karolinska Institute, Huddinge Hospital, Stockholm, Sweden.
Ringden
O
O
Aschan
J
J
Ljungman
P
P
Lönnqvist
B
B
Markling
L
L
D000328:Adult; D016026:Bone Marrow Transplantation / Q000276:immunology*; D003131:Combined Modality Therapy; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006086:Graft vs Host Disease / Q000453:epidemiology / Q000517:prevention & control; D006801:Humans; D007938:Leukemia / Q000401:mortality / Q000628:therapy*; D008212:Lymphocyte Depletion; D008727:Methotrexate / Q000627:therapeutic use*; D012008:Recurrence; D016019:Survival Analysis; D013601:T-Lymphocytes; D013997:Time Factors
D016572:Cyclosporine; D008727:Methotrexate